Design, synthesis, and evaluation of non-steroidal farnesoid X receptor (FXR) antagonist

Masahiko Kainuma, Makoto Makishima, Yuichi Hashimoto, Hiroyuki Miyachi

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

A series of substituted-isoxazole derivatives was prepared as candidate farnesoid X receptor (FXR) antagonists, based on our previously proposed ligand superfamily concept. Structure-activity relationship studies indicated that the shape and the structural bulkiness of the substituent at the 5-position of the isoxazole ring affected FXR-antagonistic activity. Compounds 15g (5-substituent: 2-naphthyl) and 15h (5-substituent: 4-biphenyl) were identified as potent antagonists with higher selectivity for FXR over progesterone receptor than the naturally occurring FXR antagonist GS. The 5-substituent is also a critical determinant of the characteristic corepressor recruitment profile of this class of FXR antagonists, though distinct mechanisms appear to be involved: 15h stabilizes the corepressor-nuclear receptor interaction, while 15g inhibits coactivator recruitment.

Original languageEnglish
Pages (from-to)2587-2600
Number of pages14
JournalBioorganic and Medicinal Chemistry
Volume15
Issue number7
DOIs
Publication statusPublished - Apr 1 2007
Externally publishedYes

Fingerprint

Isoxazoles
Co-Repressor Proteins
Progesterone Receptors
Structure-Activity Relationship
Ligands
Derivatives
diphenyl

Keywords

  • Corepressor
  • Farnesoid X receptor
  • FXR
  • FXR antagonist
  • Non-steroidal

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Organic Chemistry
  • Drug Discovery
  • Pharmaceutical Science

Cite this

Design, synthesis, and evaluation of non-steroidal farnesoid X receptor (FXR) antagonist. / Kainuma, Masahiko; Makishima, Makoto; Hashimoto, Yuichi; Miyachi, Hiroyuki.

In: Bioorganic and Medicinal Chemistry, Vol. 15, No. 7, 01.04.2007, p. 2587-2600.

Research output: Contribution to journalArticle

Kainuma, Masahiko ; Makishima, Makoto ; Hashimoto, Yuichi ; Miyachi, Hiroyuki. / Design, synthesis, and evaluation of non-steroidal farnesoid X receptor (FXR) antagonist. In: Bioorganic and Medicinal Chemistry. 2007 ; Vol. 15, No. 7. pp. 2587-2600.
@article{7c5ff6eafa9446a6b7f34d7a16effa83,
title = "Design, synthesis, and evaluation of non-steroidal farnesoid X receptor (FXR) antagonist",
abstract = "A series of substituted-isoxazole derivatives was prepared as candidate farnesoid X receptor (FXR) antagonists, based on our previously proposed ligand superfamily concept. Structure-activity relationship studies indicated that the shape and the structural bulkiness of the substituent at the 5-position of the isoxazole ring affected FXR-antagonistic activity. Compounds 15g (5-substituent: 2-naphthyl) and 15h (5-substituent: 4-biphenyl) were identified as potent antagonists with higher selectivity for FXR over progesterone receptor than the naturally occurring FXR antagonist GS. The 5-substituent is also a critical determinant of the characteristic corepressor recruitment profile of this class of FXR antagonists, though distinct mechanisms appear to be involved: 15h stabilizes the corepressor-nuclear receptor interaction, while 15g inhibits coactivator recruitment.",
keywords = "Corepressor, Farnesoid X receptor, FXR, FXR antagonist, Non-steroidal",
author = "Masahiko Kainuma and Makoto Makishima and Yuichi Hashimoto and Hiroyuki Miyachi",
year = "2007",
month = "4",
day = "1",
doi = "10.1016/j.bmc.2007.01.046",
language = "English",
volume = "15",
pages = "2587--2600",
journal = "Bioorganic and Medicinal Chemistry",
issn = "0968-0896",
publisher = "Elsevier Limited",
number = "7",

}

TY - JOUR

T1 - Design, synthesis, and evaluation of non-steroidal farnesoid X receptor (FXR) antagonist

AU - Kainuma, Masahiko

AU - Makishima, Makoto

AU - Hashimoto, Yuichi

AU - Miyachi, Hiroyuki

PY - 2007/4/1

Y1 - 2007/4/1

N2 - A series of substituted-isoxazole derivatives was prepared as candidate farnesoid X receptor (FXR) antagonists, based on our previously proposed ligand superfamily concept. Structure-activity relationship studies indicated that the shape and the structural bulkiness of the substituent at the 5-position of the isoxazole ring affected FXR-antagonistic activity. Compounds 15g (5-substituent: 2-naphthyl) and 15h (5-substituent: 4-biphenyl) were identified as potent antagonists with higher selectivity for FXR over progesterone receptor than the naturally occurring FXR antagonist GS. The 5-substituent is also a critical determinant of the characteristic corepressor recruitment profile of this class of FXR antagonists, though distinct mechanisms appear to be involved: 15h stabilizes the corepressor-nuclear receptor interaction, while 15g inhibits coactivator recruitment.

AB - A series of substituted-isoxazole derivatives was prepared as candidate farnesoid X receptor (FXR) antagonists, based on our previously proposed ligand superfamily concept. Structure-activity relationship studies indicated that the shape and the structural bulkiness of the substituent at the 5-position of the isoxazole ring affected FXR-antagonistic activity. Compounds 15g (5-substituent: 2-naphthyl) and 15h (5-substituent: 4-biphenyl) were identified as potent antagonists with higher selectivity for FXR over progesterone receptor than the naturally occurring FXR antagonist GS. The 5-substituent is also a critical determinant of the characteristic corepressor recruitment profile of this class of FXR antagonists, though distinct mechanisms appear to be involved: 15h stabilizes the corepressor-nuclear receptor interaction, while 15g inhibits coactivator recruitment.

KW - Corepressor

KW - Farnesoid X receptor

KW - FXR

KW - FXR antagonist

KW - Non-steroidal

UR - http://www.scopus.com/inward/record.url?scp=33847780436&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847780436&partnerID=8YFLogxK

U2 - 10.1016/j.bmc.2007.01.046

DO - 10.1016/j.bmc.2007.01.046

M3 - Article

C2 - 17292610

AN - SCOPUS:33847780436

VL - 15

SP - 2587

EP - 2600

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

SN - 0968-0896

IS - 7

ER -